MALARIA VACCINES

摘要

The present invention relates to a synthetic antigenic sequence which represents a combination of epitope-containing sequences from the highly polymorphic block 2 repeat region of Kl -type Plasmodium falciparum merozite surface antigen (MSPl) and fusion proteins containing that sequence. Such fusion proteins may also include a synthetic antigenic sequence similarly derived from MAD20 type block 2 repeat regions in MSPl.